Industry Educational Session - Implementing Novel Agents in RRMM in current practice - Sponsored by Pfizer
Tracks
Track 4
| Sunday, April 28, 2024 |
| 12:30 PM - 1:20 PM |
| Room 3A |
Details
This promotional symposium will review the implementation of novel agents in relapsed refractory multiple myeloma (RRMM) discussing a new therapeutic option for use in adult patients, including those with triple-class exposed RRMM.
Pfizer has sponsored and organised this symposium.
Speaker
Prof. Kwee Yong
Head of Research Department of Haematology
UCL Cancer Institute
-
Dr. Bhuvan Kishore
Consultant Haematologist
University Hospitals Birmingham
-
Dr. Hannah Giles
Consultant Haematologist
University Hospitals Birmingham
-
